Antares Pharma Inc Net Income per Employee (ATRS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Antares Pharma Inc   (NASDAQ: ATRS)
 

Antares Pharma Inc Net Income per Employee

ATRS's Quarterly Results, Trends, Rankings, Statistics
Antares Pharma Inc 's Income per employee fell in the first quarter 2022 on a trailing twelve month basis to $ 117,815, but the productivity of Antares Pharma Inc 's 341 employees remained above the company average.
The Healthcare sector has seen employees of 11 other companies achieving higher income per employee. While Antares Pharma Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 860.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRS Net Income per Employee (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Net Income Change - -36.4 % 7.95 % 103.22 % -
Net Income per Employee (TTM) $ 117,815 135,745 190,592 189,428 182,845
ATRS's Total Ranking # 860 # 0 # 0 # 0 # 0
Seq. Net Income Change - 506.03 % 22.01 % 16.53 % -92.62 %

ATRS Company Profile >> Back to ATRS Efficiency Comparisons >> Compare ATRS Net Income per Employee to its Competitors

ATRS Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 88
Overall Market # 860

Net Income per Employee Statistics
High Average Low
$ 190,592 $ -10,947 $ -103,084
(Sep 30 2021)   (Dec 31 2014)







Companies with similar Income per Employee for 12 month ending Mar 31 2022, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2022Number of Employees Mar 31 2022
Biogen Inc   205,533.33 $ 1,541.500  Million 7,500 
Seastar Medical Holding Corp  199,181.24 $ 3.386  Million 17 
Bristol myers Squibb Company  192,861.54 $ 6,268.000  Million 32,500 
Merck and Co Inc   189,186.67 $ 14,189.000  Million 75,000 
Nutriband Inc   184,591.00 $ 0.923  Million 5 
Emergent Biosolutions Inc   175,000.00 $ 157.500  Million 900 
Zura Bio Limited  168,335.30 $ 6.733  Million 40 
Harmony Biosciences Holdings inc   166,197.95 $ 48.696  Million 293 
Xenetic Biosciences Inc   160,790.00 $ 0.322  Million 2 
Quidelortho Corp  154,781.23 $ 1,006.078  Million 6,500 
Corcept Therapeutics Inc  153,210.96 $ 111.844  Million 730 
Zoetis Inc   142,758.62 $ 2,070.000  Million 14,500 
Johnson and Johnson  140,838.07 $ 19,830.000  Million 140,800 
Community Health Systems Inc   139,677.42 $ 433.000  Million 3,100 
Integrated Biopharma Inc  137,020.00 $ 6.851  Million 50 
Elite Pharmaceuticals Inc   136,896.08 $ 8.898  Million 65 
Abiomed Inc   136,505.00 $ 136.505  Million 1,000 
Organon and Co   130,000.00 $ 1,300.000  Million 10,000 
Eli Lilly And Company  122,586.00 $ 6,129.300  Million 50,000 
Zomedica Corp   120,649.65 $ 17.012  Million 141 
Shockwave Medical Inc   114,569.17 $ 28.986  Million 253 
Supernus Pharmaceuticals inc   112,493.87 $ 73.346  Million 652 
Rosecliff Acquisition Corp I  108,520.72 $ 7.054  Million 65 
Nrc Health  103,005.60 $ 36.773  Million 357 
Masimo Corp  101,299.55 $ 222.859  Million 2,200 
Collegium Pharmaceutical Inc   101,148.94 $ 42.786  Million 423 
Organogenesis Holdings Inc   99,585.48 $ 85.046  Million 854 
Intuitive Surgical Inc   97,661.71 $ 1,662.300  Million 17,021 
Edwards Lifesciences Corporation  96,156.25 $ 1,538.500  Million 16,000 
Arcus Biosciences Inc   95,557.40 $ 57.430  Million 601 


Date modified: 2026-08-29T17:23:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.